Skip to main content

Syngenta Plans US Expansion

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agricultural technology company Syngenta said it plans to build a new research facility adjacent to its existing campus in Research Triangle Park, NC, the firm said Friday.

Construction on the $71 million facility is scheduled to start in June and is expected to be operational by the second half of 2012.

The new building will include research labs, climate-controlled greenhouses and growth chambers.

Basel, Switzerland-based Syngenta plans to use the new facility to continue its corn and soybean studies and to expand into new crop areas such as sugar cane, cereals, rice, and vegetables. The genetics studies will involve efforts to develop traits that can enable plants to tolerate climate variability and drought, and to enhance productivity and plant performance.

"This investment demonstrates our commitment to R&D and to remain at the forefront of plant genetics research," Sandra Aruffo, Syngenta's head of Research and Development, said in a statement. "The advanced technologies that will be implemented at this new site will accelerate our R&D efforts to develop agronomic traits that will enable crops to better withstand complex environmental challenges."

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.